Michael Graves - 21 Dec 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Interim Executive Chair & PEO, Director
Signature
/s/ Michael Graves
Issuer symbol
EGRX
Transactions as of
21 Dec 2023
Net transactions value
$0
Form type
4
Filing time
22 Dec 2023, 19:00:19 UTC
Previous filing
31 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Employee Stock Option (right to buy) Award $0 +293,000 $0.000000 293,000 21 Dec 2023 Common Stock 293,000 $5.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted in connection with the Reporting Person's appointment as Interim Executive Chairman and Interim Principal Executive Officer. The option vests in 12 equal monthly installments commencing on November 27, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.